These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7516122)

  • 1. [New immunobiologic trends concerning etiopathogenicity of cholesteatoma].
    Bujía J
    An Otorrinolaringol Ibero Am; 1994; 21(2):199-206. PubMed ID: 7516122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional characterization of middle ear mucosa residues in cholesteatoma samples.
    Sudhoff H; Bujía J; Holly A; Kim C; Fisseler-Eckhoff A
    Am J Otol; 1994 Mar; 15(2):217-21. PubMed ID: 8172304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New aspects on the pathogenesis of cholesteatoma: the possible role of immune cell-induced keratinocyte hyperproliferation].
    Bujía J; Holly A; Kim C; Schilling V; Kastenbauer E
    Laryngorhinootologie; 1993 Jun; 72(6):279-83. PubMed ID: 8333881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxicity of cytokeratin monoclonal antibody against keratinocytes: a possible therapeutic adjunct for cholesteatoma?
    Arriaga MA; Dixon P
    Am J Otol; 1998 Jan; 19(1):26-9. PubMed ID: 9455943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible autocrine growth stimulation of cholesteatoma epithelium by transforming growth factor alpha.
    Schulz P; Bujía J; Holly A; Shilling V; Kastenbauer E
    Am J Otolaryngol; 1993; 14(2):82-7. PubMed ID: 8484481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A quantitative study of the presence of interleukin-1 and interleukin-6 in cholesteatoma of the middle ear].
    Aumente PO; Bujía J; Kim C; Jiménez Giménez J; López Villarejo P
    Acta Otorrinolaringol Esp; 1996; 47(4):259-62. PubMed ID: 8962724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesteatoma: a molecular and cellular puzzle.
    Albino AP; Kimmelman CP; Parisier SC
    Am J Otol; 1998 Jan; 19(1):7-19. PubMed ID: 9455941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The research progress of keratin's roles in the pathology of middle ear cholesteatoma].
    Feng YS; Si Y; Zhang ZG
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Nov; 54(11):870-874. PubMed ID: 31795552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunology of cholesteatoma].
    Visser CE; Veldman JE; Van Dijk CM
    Ann Otolaryngol Chir Cervicofac; 1987; 104(2):111-5. PubMed ID: 3496840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of transforming growth factor-alpha and epidermal growth factor receptor in middle ear cholesteatoma.
    Ergün S; Zheng X; Carlsöö B
    Am J Otol; 1996 May; 17(3):393-6. PubMed ID: 8817015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Angiogenesis in cholesteatoma of the middle ear].
    Bujía J; Holly A; Stammberger M; Sudhoff H
    Acta Otorrinolaringol Esp; 1996; 47(3):187-92. PubMed ID: 8924281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipopolysaccharide concentration and bone resorption in cholesteatoma.
    Peek FA; Huisman MA; Berckmans RJ; Sturk A; Van Loon J; Grote JJ
    Otol Neurotol; 2003 Sep; 24(5):709-13. PubMed ID: 14501443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistologic analysis of the cholesteatoma matrix in children.
    Mayot D; Béné MC; Faure GC; Wayoff M; Perrin C
    Int J Pediatr Otorhinolaryngol; 1991 Sep; 22(2):115-24. PubMed ID: 1720766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor receptor (EGF-R) in human middle ear cholesteatoma: an analysis of protein production and gene expression.
    Bujía J; Kim C; Holly A; Sudhoff H; Ostos P; Kastenbauer E
    Am J Otol; 1996 Mar; 17(2):203-6. PubMed ID: 8723947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cholesteatoma and bone. Petrous extensions].
    Sterkers JM; Sterkers O
    Acta Otorhinolaryngol Belg; 1980; 34(1):85-97. PubMed ID: 7468196
    [No Abstract]   [Full Text] [Related]  

  • 16. Aural cholesteatoma: role of tumor necrosis factor-alpha in bone destruction.
    Sastry KV; Sharma SC; Mann SB; Ganguly NK; Panda NK
    Am J Otol; 1999 Mar; 20(2):158-61. PubMed ID: 10100515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A murine model of cholesteatoma-induced bone resorption using autologous dermal implantation.
    Sudhoff H; Liebehenz Y; Aschenbrenner J; Jung J; Hildmann H; Dazert S
    Laryngoscope; 2003 Jun; 113(6):1022-6. PubMed ID: 12782815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cholesteatoma of the middle ear].
    Tato JM
    Rev Laryngol Otol Rhinol (Bord); 1980; 101(11-12):539-53. PubMed ID: 7221243
    [No Abstract]   [Full Text] [Related]  

  • 19. Collagenolytic activity in middle ear cholesteatoma.
    Abramson M
    Ann Otol Rhinol Laryngol; 1969 Feb; 78(1):112-24. PubMed ID: 4303159
    [No Abstract]   [Full Text] [Related]  

  • 20. The origin of congenital cholesteatoma.
    Karmody CS; Byahatti SV; Blevins N; Valtonen H; Northrop C
    Am J Otol; 1998 May; 19(3):292-7. PubMed ID: 9596177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.